Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer.

International journal of cancer - 1 Apr 2012

Razavi Pedram, Lee Eunjung, Bernstein Leslie, Van Den Berg David, Horn-Ross Pamela L, Ursin Giske

Abstract excerpt

We investigated whether variants in sex steroid hormone metabolism genes modify the effect of hormone therapy (HT) on endometrial cancer risk in postmenopausal non-Hispanic white women. A nested case-control study was conducted within the California Teachers Study (CTS). We genotyped htSNPs in six genes involved in the hormone metabolism in 286 endometrial cancer cases and 488 controls. Odds ratio (OR) and 95%...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to California
Share to Confidence Intervals

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Estrogens

Share to Gonadal Steroid Hormones

Share to Hormone Replacement Therapy

Share to Postmenopause

Share to Progestins

Source

Open in PubMed Open full text

Identifiers

PMID: 21544810
DOI: 10.1002/ijc.26163
PMCID: PMC3267886

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer.PMID 21544810Read ↗

Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype.Semantic proximity Read ↗

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.Semantic proximity Read ↗

Estrogen-related genes and their contribution to racial differences in breast cancer risk.Semantic proximity Read ↗

Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.Semantic proximity Read ↗

Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.Semantic proximity Read ↗

Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism.Semantic proximity Read ↗

Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.Semantic proximity Read ↗

Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.Semantic proximity Read ↗

<i>CYP19</i> (aromatase) haplotypes and endometrial cancer riskSemantic proximity Read ↗

Variants in hormone biosynthesis genes and risk of endometrial cancer.Semantic proximity Read ↗

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.Semantic proximity Read ↗

Association between CYP19A1 polymorphisms and sex hormones in postmenopausal Japanese women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.